uniQure-UniQure (QURE) Reports Q2 Loss, Tops Revenue Estimates

UniQure (QURE) came out with a quarterly loss of $1.16 per share versus the Zacks Consensus Estimate of a loss of$ 1.24. This compares to loss of $1.44 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 6.45%. A quarter ago, it was expected that this human gene therapy company would post a loss of$ 1.31 per share when it actually produced a loss of $1.36, delivering a surprise of -3.82%. Over the last four quarters, the company ...